Role of support measures and palliative care

Current Opinion in Pulmonary Medicine

Volumn 19, Issue 5, 2013, Pages 480-484

  Danoff, Sonye K ^a   Schonhoft, Elizabeth H ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Idiopathic pulmonary fibrosis; Palliative care; Pulmonary rehabilitation; Quality of life; Supportive care

Indexed keywords

INFLUENZA VACCINE; NARCOTIC AGENT; PNEUMOCOCCUS VACCINE;

DEPRESSION; FIBROSING ALVEOLITIS; HUMAN; INFLUENZA; LOW DRUG DOSE; MENTAL HEALTH CARE; OXYGEN THERAPY; PALLIATIVE THERAPY; PATIENT CARE; PNEUMOCOCCAL INFECTION; PULMONARY REHABILITATION; QUALITY OF LIFE; REVIEW; SURVIVAL; SYMPTOM;

DISEASE MANAGEMENT; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; IMMUNOTHERAPY, ACTIVE; OXYGEN INHALATION THERAPY; PALLIATIVE CARE; QUALITY OF LIFE; SELF-HELP GROUPS;

EID: 84881661263     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328363f4cb     Document Type: Review

References (24)

1. Spagnolo P, Tonelli R, Cocconcelli E, et al. Idiopathic pulmonary fibrosis; diagnostic pitfalls and therapeutic challenges. Multidisciplinary Respir Med 2012; 7:42
2. Bajwah S, Ross J, Peacock J, Higginson I. Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: A systematic review of the literature. Thorax 2012; http://thorax.bmj.com/content/early/ 2012/11/30/thoraxjnl-2012-202040.Abstract. [Accessed 20 April 2013]
3. O'Connell OJ, Kennedy MP, Henry MT. Idiopathic pulmonary fibrosis: Treatment update. Adv Ther 2011; 28:986-999
4. Lee JS, McLaughlin S, Collard HR. Comprehensive care of the patient with idiopathic pulmonary fibrosis. Curr Opin Pulm Med 2011; 17:348-354
5. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement; idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183:788-824
6. Brown AW, Shlobin OA, Weir N, et al. Dynamic patient counseling: A novel concept in idiopathic pulmonary fibrosis. Chest 2012; 142:1005-1010
7. Collard HR, Ward AJ, Lanes S, et al. Burden of illness in idiopathic pulmonary fibrosis. J Med Economics 2012; 15:829-835
8. Egan JJ. Follow-up and nonpharmacological management of the idiopathic pulmonary fibrosis patient. Eur Respir Rev 2011; 20:114-117
9. Lanken PN, Terry PB, Delisser HM, et al. An official American Thoracic Society clinical policy statement: Palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med 2008; 177:912-927
10. Bajwah S, Higginson I, Ross J, et al. Specialist palliative care is more than drugs: A retrospective study of ILD patients. Lung 2012; 1-6
11. Allen S, Raut S, Woollard J, Vassallo M. Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis. Palliat Med 2005; 19:128-130
12. Adamali H, Anwar M, Russell A, Egan J. Nonpharmacological treatment of idiopathic pulmonary fibrosis. Curr Respir Care 2012; 1-8
13. Bajwah S, Koffman J, Higginson I. 'I wish I knew more.' the end-of-life planning and information needs for end-stage fibrotic interstitial lung disease: Views of patients, carers and health professionals. BMJ Support Palliat Care 2013; http://spcare.bmj.com/content/3/1/84.short. [Accessed 20 April 2013]
14. Holland AE, Hill CJ, Glaspole I, et al. Predictors of benefit following pulmonary rehabilitation for interstitial lung disease. Respir Med 2012; 106:429-435
15. Huppmann P, Sczepanski B, Boensch M, et al. Effects of in-patient pulmonary rehabilitation in patients with interstitial lung disease. Eur Respir J 2012
16. Ryerson CJ, Donesky D, Pantilat SZ, Collard HR. Dyspnea in idiopathic pulmonary fibrosis: A systematic review. J Pain Symptom Manage 2012; 43:771-782
17. Kozu R, Senjyu H, Jenkins SC, et al. Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Respir Int Rev Thorac Dis 2011; 81:196-205
18. Giot C, Kirchgassler K, Maronati M. P130 Living with Idiopathic Pulmonary Fibrosis: Results of a European Patient Survey. Thorax 2012; http:// thorax.bmj.com/content/67/Suppl-2/A118.2.abstract. [Accessed 20 April 2013]
19. Ryerson CJ, Arean PA, Berkeley J, et al. Depression is a common and chronic comorbidity in patients with interstitial lung disease. Respirology 2012; 17:525-532
20. Behr J, Richeldi L. Recommendations on treatment for IPF. Respir Res 2013; http://respiratory-research.com/content/14/S1/S6/. [Accessed 31 May 2013]
21. Swinburn CR, Mould H, Stone TN. Symptomatic benefit of supplemental oxygen in hypoxemic patients with chronic lung disease. Am Rev Respir Dis 1991; 143:913-915
22. Hook J, Arcasoy S, Zemmel D, Bartels M. Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis. Eur Respir 2012; http:// www.ersj.org.uk/content/39/2/359.short. [Accessed 31 May 2013]
23. Swetz KM, Carey EC, Bundrick JB. Clinical pearls in palliative medicine 2012. Mayo Clinic proceedings. Mayo Clin 2012; 87:1118-1123
24. Litinsky I, Balbir A, Zisman D, et al. Vaccination against influenza in patients with systemic sclerosis. Clin Exp Rheumatol 2012; 30 (2 Suppl 71):S7-S11